Novo Nordisk: controls 2.2 percent of own shares
(CercleFinance.com) - Denmark's Novo Nordisk owned on 31 December 2017 55.
5 million of its own B shares, or 2.2% of the total capital, the drugmaker said on Tuesday.
In the fourth quarter of 2017, the firm repurchased close to 14 million B shares, while 4,329 B shares were sold to employees as part of employee incentive programmes, it said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
5 million of its own B shares, or 2.2% of the total capital, the drugmaker said on Tuesday.
In the fourth quarter of 2017, the firm repurchased close to 14 million B shares, while 4,329 B shares were sold to employees as part of employee incentive programmes, it said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.